FORMA THERAPEUTICS HOLDINGS, INC. Operating Expenses
FORMA THERAPEUTICS HOLDINGS, INC. reported Operating Expenses of $53.00 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-08-05
- FORMA THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2022-06-30 was $53.00M, a 20.29% increase year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2022-03-31 was $44.41M, a 22.64% increase year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2021-12-31 was $50.28M, a 53.28% increase year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2021-09-30 was $43.43M, a 34.72% increase year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. operating expenses for fiscal 2021 was $173.99M, a 40.07% increase from fiscal 2020.
- FORMA THERAPEUTICS HOLDINGS, INC. operating expenses for fiscal 2020 was $124.21M, a 11.91% decline from fiscal 2019.
- FORMA THERAPEUTICS HOLDINGS, INC. operating expenses for fiscal 2019 was $141.01M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2022-06-30 | $53.00M 10-Q · filed 2022-08-05 | $97.41M 10-Q · filed 2022-08-05 | $147.69M derived: sum of 3 quarters · filed 2022-08-05 | $191.13M derived: sum of 4 quarters · filed 2022-08-05 |
| 2022-03-31 | $44.41M 10-Q · filed 2022-05-06 | $94.69M derived: sum of 2 quarters · filed 2022-05-06 | $138.13M derived: sum of 3 quarters · filed 2022-05-06 | $182.19M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-12-31 | $50.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $93.72M derived: sum of 2 quarters · filed 2022-03-01 | $137.78M derived: sum of 3 quarters · filed 2022-08-05 | $173.99M 10-K · filed 2022-03-01 |
| 2021-09-30 | $43.43M 10-Q · filed 2021-11-12 | $87.49M derived: sum of 2 quarters · filed 2022-08-05 | $123.70M 10-Q · filed 2021-11-12 | $156.51M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-06-30 | $44.06M 10-Q · filed 2022-08-05 | $80.27M 10-Q · filed 2022-08-05 | $113.08M derived: sum of 3 quarters · filed 2022-08-05 | $145.31M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $36.21M 10-Q · filed 2022-05-06 | $69.02M derived: sum of 2 quarters · filed 2022-05-06 | $101.26M derived: sum of 3 quarters · filed 2022-05-06 | $128.20M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $32.81M 10-K · filed 2021-03-30 | $65.05M derived: sum of 2 quarters · filed 2021-11-12 | $91.99M derived: sum of 3 quarters · filed 2021-11-12 | $124.21M 10-K · filed 2022-03-01 |
| 2020-09-30 | $32.24M 10-Q · filed 2021-11-12 | $59.18M derived: sum of 2 quarters · filed 2021-11-12 | $91.41M 10-Q · filed 2021-11-12 | $124.89M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $26.94M 10-Q · filed 2021-08-13 | $59.16M 10-Q · filed 2021-08-13 | $92.65M derived: sum of 3 quarters · filed 2021-08-13 | $127.78M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $32.23M 10-Q · filed 2021-05-14 | $65.71M derived: sum of 2 quarters · filed 2021-05-14 | $100.84M derived: sum of 3 quarters · filed 2021-05-14 | $135.44M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $33.48M 10-K · filed 2021-03-30 | $68.61M derived: sum of 2 quarters · filed 2021-03-30 | $103.21M derived: sum of 3 quarters · filed 2021-03-30 | $141.01M 10-K · filed 2021-03-30 |
| 2019-09-30 | $35.13M 10-K · filed 2021-03-30 | $69.73M derived: sum of 2 quarters · filed 2021-03-30 | $107.52M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $34.60M 10-K · filed 2021-03-30 | $72.40M 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $37.79M 10-K · filed 2021-03-30 |